Center-Authored Papers

Filters: Author is Porter, Peggy  [Clear All Filters]
Journal Article
Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D et al..  2017.  Analysis of ROR1 protein expression in human cancer and normal tissues.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(12):3061-3071. Abstract
Anderson N, Ponko S, Black T, Prosser J, Stein B, Tarczy-Hornoch P, Porter P.  2013.  Biotrust: a comprehensive system for acquiring and distributing biospecimens.. AMIA Summits on Translational Science proceedings AMIA Summit on Translational Science. 2013:4. Abstract
Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DSM.  2013.  Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.. Cancer causes & control : CCC. 24(2):305-12. Abstract
Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA et al..  2013.  A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 16(3):431-40. Abstract
Rodler ET, Kurland BF, Griffin M, Gralow JR, Porter P, Yeh RF, Gadi VK, Guenthoer J, Beumer JH, Korde L et al..  2016.  Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 22(12):2855-2864. Abstract
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y et al..  2013.  Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.. Journal of the National Cancer Institute. 105(14):1036-1042. Abstract
Chen L, Li CI, Tang M-TC, Porter P, Hill DA, Wiggins CL, Cook LS.  2016.  Reproductive factors and risk of luminal, HER2-overexpressing and triple negative breast cancer among multiethnic women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC.  2016.  Screening MRI in Women With a Personal History of Breast Cancer.. Journal of the National Cancer Institute. 108(3) Abstract
Gamble LJ, Graham DJ, Bluestein B, Whitehead NP, Hockenbery D, Morrish F, Porter P.  2015.  ToF-SIMS of tissues: "lessons learned" from mice and women.. Biointerphases. 10(1):019008. Abstract
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS.  2012.  Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.. Nature medicine. Abstract